With 150 years of experience in solving complex challenges,
we at Mallinckrodt Pharmaceuticals believe in producing high-quality specialty pharmaceuticals.

Card image cap

THERAKOS® CELLEX® Photopheresis System
using UVADEX® (methoxsalen)

  • World's only fully integrated closed ECP system1
  • Since launching over 30 years ago, there have been over 1 million THERAKOS® Photopheresis treatments given1,2
  • Can be used to treat cutaneous T-cell lymphoma (CTCL) and patients with chronic graft-versus-host disease (cGVHD)3
  • For use with UVADEX® (methoxsalen) 3
pdf-icon Download the UVADEX® Product Information
pdf-icon Download the UVADEX® Consumer Medicine Information
pdf-icon Download the THERAKOS® CELLEX® Operator’s Manual
Card image cap

INOmax
DSIR® Plus

  • An all-inclusive offering of INOmax® services & technologies.
  • Includes our registered pharmaceutical grade INOmax® (nitric oxide) for inhalation4
  • Includes INOcal calibration gases, use of our proprietary registered drug-delivery system4
pdf-icon Download the INOmax® Product Information
pdf-icon Download the INOmax® Consumer Medicine Information
pdf-icon Download the INOmax DSIR Plus CE Operational Manual
pdf-icon Access the Neonatal Parent Education Tools

Create a Healthcare Professional Account

Gain access to learn more about THERAKOS® CELLEX® & INOmax®, including:

  • An in depth look at how the Products work
  • Efficacy Data
  • Safety Data
  • Educational Materials & Videos
  • Ordering forms

References

  1. Knobler R, et al. J Eur Acad Dermatol Venereol. 2014;28 Suppl 1:1-37
  2. Cho A, et al. Front Med (Lausanne). 2018;5:236
  3. UVADEX® Australian Product Information
  4. INOmax® Australian Product Information